» Articles » PMID: 18662989

Critical and Distinct Roles of P16 and Telomerase in Regulating the Proliferative Life Span of Normal Human Prostate Epithelial Progenitor Cells

Abstract

Normal human prostate (NHP) epithelial cells undergo senescence in vitro and in vivo, but the underlying molecular mechanisms remain obscure. Here we show that the senescence of primary NHP cells, which are immunophenotyped as intermediate basal-like cells expressing progenitor cell markers CD44, alpha2beta1, p63, hTERT, and CK5/CK18, involves loss of telomerase expression, up-regulation of p16, and activation of p53. Using genetically defined manipulations of these three signaling pathways, we show that p16 is the primary determinant of the NHP cell proliferative capacity and that hTERT is required for unlimited proliferative life span. Hence, suppression of p16 significantly extends NHP cell life span, but both p16 inhibition and hTERT are required to immortalize NHP cells. Importantly, immortalized NHP cells retain expression of most progenitor markers, demonstrate gene expression profiles characteristic of proliferating progenitor cells, and possess multilineage differentiation potential generating functional prostatic glands. Our studies shed important light on the molecular mechanisms regulating the proliferative life span of NHP progenitor cells.

Citing Articles

Human intermediate prostate cancer stem cells contribute to the initiation and development of prostate adenocarcinoma.

Mu J, Li R, Zheng Y, Lu Y, Ma L, Yin L Stem Cell Res Ther. 2024; 15(1):296.

PMID: 39256886 PMC: 11389492. DOI: 10.1186/s13287-024-03917-8.


Derivation of human primary prostate epithelial cell lines by differentially targeting the CDKN2A locus along with expression of hTERT.

Wasserman J, Fowle H, Hashmi R, Atar D, Patel K, Yarmahmoodi A Sci Rep. 2024; 14(1):20409.

PMID: 39223207 PMC: 11369182. DOI: 10.1038/s41598-024-71306-5.


Derivation of human primary prostate epithelial cell lines by differentially targeting the locus along with expression of hTERT.

Wasserman J, Fowle H, Hashmi R, Atar D, Patel K, Yarmahmoodi A Res Sq. 2024; .

PMID: 38766032 PMC: 11100872. DOI: 10.21203/rs.3.rs-4294058/v1.


Understanding and targeting prostate cancer cell heterogeneity and plasticity.

Tang D Semin Cancer Biol. 2021; 82:68-93.

PMID: 34844845 PMC: 9106849. DOI: 10.1016/j.semcancer.2021.11.001.


Upregulated PPARG2 facilitates interaction with demethylated AKAP12 gene promoter and suppresses proliferation in prostate cancer.

Li F, Lu T, Liu D, Zhang C, Zhang Y, Dong F Cell Death Dis. 2021; 12(6):528.

PMID: 34023860 PMC: 8141057. DOI: 10.1038/s41419-021-03820-7.


References
1.
Tang D, Tokumoto Y, Apperly J, Lloyd A, Raff M . Lack of replicative senescence in cultured rat oligodendrocyte precursor cells. Science. 2001; 291(5505):868-71. DOI: 10.1126/science.1056780. View

2.
Berger R, Febbo P, Majumder P, Zhao J, Mukherjee S, Signoretti S . Androgen-induced differentiation and tumorigenicity of human prostate epithelial cells. Cancer Res. 2004; 64(24):8867-75. DOI: 10.1158/0008-5472.CAN-04-2938. View

3.
Lawson D, Witte O . Stem cells in prostate cancer initiation and progression. J Clin Invest. 2007; 117(8):2044-50. PMC: 1934594. DOI: 10.1172/JCI32810. View

4.
Huang W, Wu D, Xie Z, Zhau H, Nomura T, Zayzafoon M . beta2-microglobulin is a signaling and growth-promoting factor for human prostate cancer bone metastasis. Cancer Res. 2006; 66(18):9108-16. DOI: 10.1158/0008-5472.CAN-06-1996. View

5.
Kim W, Sharpless N . The regulation of INK4/ARF in cancer and aging. Cell. 2006; 127(2):265-75. DOI: 10.1016/j.cell.2006.10.003. View